Selected research
Market Structure
Global Genome Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Genome Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genome Sequencing Service include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Genome Sequencing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genome Sequencing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genome Sequencing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genome Sequencing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Genome Sequencing Service Segment by Company
Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
CD Genomics
Azenta Life Sciences
Broad Clinical Labs
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
GeneDx
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen
Genome Sequencing Service Segment by Type
Whole-Genome Sequencing
Whole exome Sequencing
Others
Genome Sequencing Service Segment by Application
Humanity
Plant
Animal
Microorganism
Virus
Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genome Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genome Sequencing Service industry.
Chapter 3: Detailed analysis of Genome Sequencing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome Sequencing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole-Genome Sequencing
- Whole exome Sequencing
- Others
Applications
- Humanity
- Plant
- Animal
- Microorganism
- Virus
Companies covered
- Illumina
- Thermo Fisher Scientific
- BGI Genomics
- Agilent Technologies
- CD Genomics
- Azenta Life Sciences
- Broad Clinical Labs
- Macrogen
- GE Healthcare Life Sciences
- Johnson & Johnson
- Abbott Laboratories
- Bayer
- Microchip Biotechnologies
- GeneDx
- Commonwealth Biotechnologies
- ZS Genetics
- Pacific Biosciences
- Novogene
- Eurofins Genomics
- Psomagen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Genome Sequencing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Whole-Genome Sequencing
- 1.2.3 Whole exome Sequencing
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Genome Sequencing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Humanity
- 1.3.3 Plant
- 1.3.4 Animal
- 1.3.5 Microorganism
- 1.3.6 Virus
- 1.4 Global Market Growth Prospects
- 1.5 Global Genome Sequencing Service Growth Trends by Region
- 1.5.1 Global Genome Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Genome Sequencing Service Market Size by Region (2021-2026)
- 1.5.3 Genome Sequencing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Genome Sequencing Service Market Dynamics
- 2.1 Genome Sequencing Service Industry Trends
- 2.2 Genome Sequencing Service Industry Drivers
- 2.3 Genome Sequencing Service Industry Opportunities and Challenges
- 2.4 Genome Sequencing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Genome Sequencing Service Revenue by Company (2021-2026)
- 3.2 Global Genome Sequencing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Genome Sequencing Service Key Company Head office and Area Served
- 3.4 Global Genome Sequencing Service Company, Product Type & Application
- 3.5 Global Genome Sequencing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Genome Sequencing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Genome Sequencing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Genome Sequencing Service Tier 1, Tier 2, and Tier 3
4 Genome Sequencing Service Market by Type
- 4.1 Global Genome Sequencing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Genome Sequencing Service Market Size by Type (2021-2032)
- 4.3 Global Genome Sequencing Service Market Size Share by Type (2021-2032)
5 Genome Sequencing Service Market by Application
- 5.1 Global Genome Sequencing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Genome Sequencing Service Market Size by Application (2021-2032)
- 5.3 Global Genome Sequencing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Illumina Genome Sequencing Service Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 BGI Genomics
- 6.3.1 BGI Genomics Company Information
- 6.3.2 BGI Genomics Business Overview
- 6.3.3 BGI Genomics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
- 6.3.5 BGI Genomics Recent Developments
- 6.4 Agilent Technologies
- 6.4.1 Agilent Technologies Company Information
- 6.4.2 Agilent Technologies Business Overview
- 6.4.3 Agilent Technologies Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
- 6.4.5 Agilent Technologies Recent Developments
- 6.5 CD Genomics
- 6.5.1 CD Genomics Company Information
- 6.5.2 CD Genomics Business Overview
- 6.5.3 CD Genomics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CD Genomics Genome Sequencing Service Product Portfolio
- 6.5.5 CD Genomics Recent Developments
- 6.6 Azenta Life Sciences
- 6.6.1 Azenta Life Sciences Company Information
- 6.6.2 Azenta Life Sciences Business Overview
- 6.6.3 Azenta Life Sciences Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
- 6.6.5 Azenta Life Sciences Recent Developments
- 6.7 Broad Clinical Labs
- 6.7.1 Broad Clinical Labs Company Information
- 6.7.2 Broad Clinical Labs Business Overview
- 6.7.3 Broad Clinical Labs Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
- 6.7.5 Broad Clinical Labs Recent Developments
- 6.8 Macrogen
- 6.8.1 Macrogen Company Information
- 6.8.2 Macrogen Business Overview
- 6.8.3 Macrogen Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Macrogen Genome Sequencing Service Product Portfolio
- 6.8.5 Macrogen Recent Developments
- 6.9 GE Healthcare Life Sciences
- 6.9.1 GE Healthcare Life Sciences Company Information
- 6.9.2 GE Healthcare Life Sciences Business Overview
- 6.9.3 GE Healthcare Life Sciences Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
- 6.9.5 GE Healthcare Life Sciences Recent Developments
- 6.10 Johnson & Johnson
- 6.10.1 Johnson & Johnson Company Information
- 6.10.2 Johnson & Johnson Business Overview
- 6.10.3 Johnson & Johnson Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
- 6.10.5 Johnson & Johnson Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
- 6.12 Bayer
- 6.12.1 Bayer Company Information
- 6.12.2 Bayer Business Overview
- 6.12.3 Bayer Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Bayer Genome Sequencing Service Product Portfolio
- 6.12.5 Bayer Recent Developments
- 6.13 Microchip Biotechnologies
- 6.13.1 Microchip Biotechnologies Company Information
- 6.13.2 Microchip Biotechnologies Business Overview
- 6.13.3 Microchip Biotechnologies Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
- 6.13.5 Microchip Biotechnologies Recent Developments
- 6.14 GeneDx
- 6.14.1 GeneDx Company Information
- 6.14.2 GeneDx Business Overview
- 6.14.3 GeneDx Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 GeneDx Genome Sequencing Service Product Portfolio
- 6.14.5 GeneDx Recent Developments
- 6.15 Commonwealth Biotechnologies
- 6.15.1 Commonwealth Biotechnologies Company Information
- 6.15.2 Commonwealth Biotechnologies Business Overview
- 6.15.3 Commonwealth Biotechnologies Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
- 6.15.5 Commonwealth Biotechnologies Recent Developments
- 6.16 ZS Genetics
- 6.16.1 ZS Genetics Company Information
- 6.16.2 ZS Genetics Business Overview
- 6.16.3 ZS Genetics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
- 6.16.5 ZS Genetics Recent Developments
- 6.17 Pacific Biosciences
- 6.17.1 Pacific Biosciences Company Information
- 6.17.2 Pacific Biosciences Business Overview
- 6.17.3 Pacific Biosciences Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
- 6.17.5 Pacific Biosciences Recent Developments
- 6.18 Novogene
- 6.18.1 Novogene Company Information
- 6.18.2 Novogene Business Overview
- 6.18.3 Novogene Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Novogene Genome Sequencing Service Product Portfolio
- 6.18.5 Novogene Recent Developments
- 6.19 Eurofins Genomics
- 6.19.1 Eurofins Genomics Company Information
- 6.19.2 Eurofins Genomics Business Overview
- 6.19.3 Eurofins Genomics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
- 6.19.5 Eurofins Genomics Recent Developments
- 6.20 Psomagen
- 6.20.1 Psomagen Company Information
- 6.20.2 Psomagen Business Overview
- 6.20.3 Psomagen Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Psomagen Genome Sequencing Service Product Portfolio
- 6.20.5 Psomagen Recent Developments
7 North America
- 7.1 North America Genome Sequencing Service Market Size (2021-2032)
- 7.2 North America Genome Sequencing Service Market Size by Type
- 7.2.1 North America Genome Sequencing Service Market Size by Type (2021-2026)
- 7.2.2 North America Genome Sequencing Service Market Size by Type (2027-2032)
- 7.2.3 North America Genome Sequencing Service Market Share by Type (2021-2032)
- 7.3 North America Genome Sequencing Service Market Size by Application
- 7.3.1 North America Genome Sequencing Service Market Size by Application (2021-2026)
- 7.3.2 North America Genome Sequencing Service Market Size by Application (2027-2032)
- 7.3.3 North America Genome Sequencing Service Market Share by Application (2021-2032)
- 7.4 North America Genome Sequencing Service Market Size by Country
- 7.4.1 North America Genome Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Genome Sequencing Service Market Size by Country (2021-2026)
- 7.4.3 North America Genome Sequencing Service Market Size by Country (2027-2032)
- 7.4.4 North America Genome Sequencing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Genome Sequencing Service Market Size (2021-2032)
- 8.2 Europe Genome Sequencing Service Market Size by Type
- 8.2.1 Europe Genome Sequencing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Genome Sequencing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Genome Sequencing Service Market Share by Type (2021-2032)
- 8.3 Europe Genome Sequencing Service Market Size by Application
- 8.3.1 Europe Genome Sequencing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Genome Sequencing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Genome Sequencing Service Market Share by Application (2021-2032)
- 8.4 Europe Genome Sequencing Service Market Size by Country
- 8.4.1 Europe Genome Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Genome Sequencing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Genome Sequencing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Genome Sequencing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Genome Sequencing Service Market Size (2021-2032)
- 9.2 China Genome Sequencing Service Market Size by Type
- 9.2.1 China Genome Sequencing Service Market Size by Type (2021-2026)
- 9.2.2 China Genome Sequencing Service Market Size by Type (2027-2032)
- 9.2.3 China Genome Sequencing Service Market Share by Type (2021-2032)
- 9.3 China Genome Sequencing Service Market Size by Application
- 9.3.1 China Genome Sequencing Service Market Size by Application (2021-2026)
- 9.3.2 China Genome Sequencing Service Market Size by Application (2027-2032)
- 9.3.3 China Genome Sequencing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Genome Sequencing Service Market Size (2021-2032)
- 10.2 Asia Genome Sequencing Service Market Size by Type
- 10.2.1 Asia Genome Sequencing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Genome Sequencing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Genome Sequencing Service Market Share by Type (2021-2032)
- 10.3 Asia Genome Sequencing Service Market Size by Application
- 10.3.1 Asia Genome Sequencing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Genome Sequencing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Genome Sequencing Service Market Share by Application (2021-2032)
- 10.4 Asia Genome Sequencing Service Market Size by Country
- 10.4.1 Asia Genome Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Genome Sequencing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Genome Sequencing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Genome Sequencing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Genome Sequencing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Genome Sequencing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Genome Sequencing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Genome Sequencing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Genome Sequencing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Genome Sequencing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Genome Sequencing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Genome Sequencing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Genome Sequencing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Genome Sequencing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Genome Sequencing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Genome Sequencing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Genome Sequencing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Genome Sequencing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst